A Systematic Review of the Effects of Exercise on Hormones in Women with Polycystic Ovary Syndrome
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder that is characterized by menstrual irregularity and elevated serum androgens, and is often accompanied by insulin resistance. The etiology of PCOS is unknown. Lifestyle interventions and weight loss, where appropriate, remain first-line treatments for women with PCOS. Regular physical activity is recommended for women with PCOS to maintain a healthy weight and cardiovascular fitness. Purpose: To review the evidence for the impact of various exercise interventions on hormone levels in women with PCOS. Methods: A systematic review of original studies indexed in PubMed that utilized an exercise intervention in women with PCOS and reported hormone values pre- and post-intervention. Studies in which the effects of the exercise intervention could be determined were included. Results: Vigorous aerobic exercise improves insulin measures in women with PCOS. Resistance or strength training may improve androgen levels, though additional studies are warranted. Studies with yoga are limited but suggest improvements in androgens. Limited information is available on the impact of exercise on adipokines and anti-Müllerian hormone, warranting further investigation. Conclusions: Recommended guidelines for women with PCOS include vigorous aerobic exercise and resistance training to improve measures of insulin sensitivity and androgen levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463 · cited 4×
“subjects both with PCOS and without and did not include a PCOS subgroup analysis [1].”
BackgroundMethodInfluentialAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · cited 1×
“Most often, the androgen used to assess hyperandrogenemia is free testosterone (fT), although total testosterone (TT), sex hormone binding globulin (SHBG), the free androgen index (FAI), dehydroepiandrosterone (DHEA), DHEA sulfate (DHEA-S), and androstenedione (A4) may also be altered [6].”
BackgroundMarch, W. A., Moore, V. M., Willson, K. J., Phillips, D. I. W., Norman, R. J., & Davies, M. J. (2010) · Human Reproduction · doi:10.1093/humrep/dep399 · Cited by 1,799
Teede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561 · cited 1×
“However, insulin resistance in women with PCOS has been attributed to increased insulin receptor and insulin receptor substrate 1 (IRS1) serine phosphorylation in muscle [40], with impaired insulin signaling that affects the metabolic but not the mitogenic pathway [41–44].”
BackgroundMoran, L. J., Pasquali, R., Teede, H. J., Hoeger, K. M., & Norman, R. J. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.09.018 · Cited by 444
The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism
Wallach, E. E., Barbieri, R. L., Smith, S., & Ryan, K. J. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60060-2 · Cited by 348
Cellular mechanisms of insulin resistance in polycystic ovarian syndrome
Ciaraldi, T. P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.2.577 · Cited by 336
Slentz, C. A., Aiken, L. B., Houmard, J. A., Bales, C. W., Johnson, J. L., Tanner, C. J., Duscha, B. D., & Kraus, W. E. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00124.2005 · Cited by 296
Corbould, A., Kim, Y.-B., Youngren, J. F., Pender, C., Kahn, B. B., Lee, A., & Dunaif, A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00361.2004 · Cited by 283
Thomson, R. L., Buckley, J. D., Noakes, M., Clifton, P. M., Norman, R. J., & Brinkworth, G. D. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0751 · Cited by 277
Women with polycystic ovary syndrome are often depressed or anxious—A case control study
Månsson, M., Holte, J., Landin-Wilhelmsen, K., Dahlgren, E., Johansson, A., & Landén, M. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.06.003 · Cited by 260
Metabolic risk in PCOS: Phenotype and adiposity impact
Moran, L. J., Norman, R. J., & Teede, H. J. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.12.003 · Cited by 245
Palomba, S., Giallauria, F., Falbo, A., Russo, T., Oppedisano, R., Tolino, A., Colao, A., Vigorito, C., Zullo, F., & Orio, F. (2008) · Human Reproduction · doi:10.1093/humrep/dem391 · Cited by 235
Slentz, C. A., Bateman, L. A., Willis, L. H., Shields, A. T., Tanner, C. J., Piner, L. W., Hawk, V. H., Muehlbauer, M. J., Samsa, G. P., Nelson, R. C., et al. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00291.2011 · Cited by 235
Vigorito, C., Giallauria, F., Palomba, S., Cascella, T., Manguso, F., Lucci, R., De Lorenzo, A., Tafuri, D., Lombardi, G., Colao, A., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2794 · Cited by 211
Farrell, K., & Antoni, M. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.081 · Cited by 209
Deeks, A. A., Gibson-Helm, M. E., Paul, E., & Teede, H. J. (2011) · Human Reproduction · doi:10.1093/humrep/der071 · Cited by 202
Stener-Victorin, E., Jedel, E., Janson, P. O., & Sverrisdottir, Y. B. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00197.2009 · Cited by 194 · cited 1×
“Aerobic exercise interventions generally did not alter the LH or FSH levels in women with PCOS [84,86,88,92,97,100,101,110,111,133].”
BackgroundHutchison, S. K., Stepto, N. K., Harrison, C. L., Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0828 · Cited by 192
Vryonidou, A., Papatheodorou, A., Tavridou, A., Terzi, T., Loi, V., Vatalas, I.-A., Batakis, N., Phenekos, C., & Dionyssiou-Asteriou, A. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2363 · Cited by 171
Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome
Cinar, N., Kizilarslanoglu, M. C., Harmanci, A., Aksoy, D. Y., Bozdag, G., Demir, B., & Yildiz, B. O. (2011) · Human Reproduction · doi:10.1093/humrep/der338 · Cited by 168
Benson, S., Hahn, S., Tan, S., Mann, K., Janssen, O. E., Schedlowski, M., & Elsenbruch, S. (2009) · Human Reproduction · doi:10.1093/humrep/dep031 · Cited by 160
Almenning, I., Rieber-Mohn, A., Lundgren, K. M., Shetelig Løvvik, T., Garnæs, K. K., & Moholdt, T. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138793 · Cited by 155
Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause
Welt, C. K., & Carmina, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2375 · Cited by 148
Cussons, A. J., Watts, G. F., Burke, V., Shaw, J. E., Zimmet, P. Z., & Stuckey, B. G. A. (2008) · Human Reproduction · doi:10.1093/humrep/den263 · Cited by 140
The management of insulin resistance in polycystic ovary syndrome
Teede, H. J., Hutchison, S. K., & Zoungas, S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.08.001 · Cited by 135
Effects of Exercise and Nutritional Counseling in Women with Polycystic Ovary Syndrome
Bruner, B., Chad, K., & Chizen, D. (2006) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h06-007 · Cited by 133
Physical activity and mental health in women with Polycystic Ovary Syndrome
Banting, L. K., Gibson-Helm, M., Polman, R., Teede, H. J., & Stepto, N. K. (2014) · BMC Women's Health · doi:10.1186/1472-6874-14-51 · Cited by 121
Konopka, A. R., Asante, A., Lanza, I. R., Robinson, M. M., Johnson, M. L., Dalla Man, C., Cobelli, C., Amols, M. H., Irving, B. A., & Nair, K. S. (2015) · Diabetes · doi:10.2337/db14-1701 · Cited by 112 · cited 12×
“Cycling more frequently and for a longer duration during a 12-week period, for 60 min five days per week at 65% VO2max, did not yield changes to FI or the homeostatic model assessment of insulin resistance (HOMA-IR), but did result in improvement in insulin sensitivity (IS) and the glucose infusion rate (GIR) during a…”
BackgroundMethodInfluentialLaggari, V., Diareme, S., Christogiorgos, S., Deligeoroglou, E., Christopoulos, P., Tsiantis, J., & Creatsas, G. (2009) · Journal of Psychosomatic Obstetrics & Gynecology · doi:10.1080/01674820802546204 · Cited by 99
Diet and nutrition in polycystic ovary syndrome (PCOS): Pointers for nutritional management
Farshchi, H., Rane, A., Love, A., & Kennedy, R. L. (2007) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610701667338 · Cited by 87 · cited 1×
“One of the first lines of advice for managing PCOS symptoms is weight loss, where appropriate, coupled with a healthy, well-balanced diet [50,53,82].”
BackgroundAerobic Training Improves Quality of Life in Women with Polycystic Ovary Syndrome
COSTA, E. C., DE SÁ, J. C. F., STEPTO, N. K., COSTA, I. B. B., FARIAS-JUNIOR, L. F., MOREIRA, S. D. N. T., SOARES, E. M. M., LEMOS, T. M. A. M., BROWNE, R. A. V., & AZEVEDO, G. D. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001579 · Cited by 71 · cited 2×
“With respect to studies involving walking or jogging, a 16-week progressive aerobic training program supervised on an indoor track for 50 min three days per week did not yield changes in FI or HOMA-IR [89].”
BackgroundTuran, V., Mutlu, E. K., Solmaz, U., Ekin, A., Tosun, O., Tosun, G., Mat, E., Gezer, C., & Malkoc, M. (2015) · Journal of Physical Therapy Science · doi:10.1589/jpts.27.2293 · Cited by 55
The effects of aerobic physical exercises on body image among women with polycystic ovary syndrome
Kogure, G. S., Lopes, I. P., Ribeiro, V. B., Mendes, M. C., Kodato, S., Furtado, C. L. M., Silva de Sá, M. F., Ferriani, R. A., Lara, L. A. D. S., & Reis, R. M. D. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.11.025 · Cited by 53 · cited 2×
“Evidence from RCTs and case–control or single-arm studies with exercise intervention protocols that involved aerobic exercise at a specified VO2max collectively showed improvements in FI [84,86,88, 93,101], AUCins [84,86,133], or other measures of insulin responsiveness such as GIR [87,88], IS [87,108], HOMA-IR [88,10…”
BackgroundTiwari, N., Pasrija, S., & Jain, S. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.12.021 · Cited by 50
Nybacka, Å., Hellström, P. M., & Hirschberg, A. L. (2017) · Clinical Endocrinology · doi:10.1111/cen.13427 · Cited by 50
Mario, F. M., Graff, S. K., & Spritzer, P. M. (2017) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0570-1 · Cited by 47
Samadi, Z., Bambaeichi, E., Valiani, M., & Shahshahan, Z. (2019) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_360_18 · Cited by 38
Mario, F., do Amarante, F., Toscani, M., & Spritzer, P. (2012) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0032-1309006 · Cited by 37
Research works printed but not linked: 100
- Lujan, 2008, Diagnostic Criteria for Polycystic Ovary Syndrome: Pitfalls and Controversies, J. Obstet. Gynaecol. Can., 30, 671, 10.1016/S1701-2163(16)32915-2 · DOI · Paper page
- Raj, 1978, Diagnostic value of androgen measurements in polycystic ovary syndrome, Obstet. Gynecol., 52, 169
- Stuckey, 2014, Clustering of metabolic and cardiovascular risk factors in the polycystic ovary syndrome: A principal component analysis, Metabolism, 63, 1071, 10.1016/j.metabol.2014.05.004 · DOI
- Talbott, 2000, Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women, Arter. Thromb. Vasc. Boil., 20, 2414, 10.1161/01.ATV.20.11.2414 · DOI · Paper page
- Boulman, 2004, Increased C-Reactive Protein Levels in the Polycystic Ovary Syndrome: A Marker of Cardiovascular Disease, J. Clin. Endocrinol. Metab., 89, 2160, 10.1210/jc.2003-031096 · DOI · Paper page
- Tarkun, 2004, Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome: Relationship with Insulin Resistance and Low-Grade Chronic Inflammation, J. Clin. Endocrinol. Metab., 89, 5592, 10.1210/jc.2004-0751 · DOI · Paper page
- Teede, 2006, Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS, Endocrine, 30, 45, 10.1385/ENDO:30:1:45 · DOI
- Motalebi, 2014, Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis, Hepat. Mon., 14, 23235
- Weiner, 2004, Androgens and mood dysfunction in women: Comparison of women with polycystic ovarian syndrome to healthy controls, Psychosom. Med., 66, 356
- Deeks, 2010, Anxiety and depression in polycystic ovary syndrome: A comprehensive investigation, Fertil. Steril., 93, 2421, 10.1016/j.fertnstert.2009.09.018 · DOI · Paper page
- Jedel, 2009, Anxiety and depression symptoms in women with polycystic ovary syndrome compared with controls matched for body mass index, Hum. Reprod., 25, 450, 10.1093/humrep/dep384 · DOI · Paper page
- Rassi, 2010, Prevalence of psychiatric disorders in patients with polycystic ovary syndrome, Compr. Psychiatry, 51, 599, 10.1016/j.comppsych.2010.02.009 · DOI
- Barry, 2011, Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls, J. Psychosom. Obstet. Gynecol., 32, 104, 10.3109/0167482X.2011.568129 · DOI
- Livadas, 2011, Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome, Clin. Endocrinol., 75, 698, 10.1111/j.1365-2265.2011.04122.x · DOI · Paper page
- Dokras, 2012, Mood and anxiety disorders in women with PCOS, Steroids, 77, 338, 10.1016/j.steroids.2011.12.008 · DOI
- Lenarcik, 2012, Psychiatric disorders related to polycystic ovary syndrome, Endokrynol. Polska, 63, 488
- Albayrak, 2013, Level of anxiety, depression, self-esteem, social anxiety, and quality of life among the women with polycystic ovary syndrome, Sci. World J., 2013, 851815, 10.1155/2013/851815 · DOI
- Mahajan, 1988, Steroidogenesis in Human Polycystic Ovary, Endocrinol. Metab. Clin. N. Am., 17, 751, 10.1016/S0889-8529(18)30408-0 · DOI
- Barnes, 1998, The pathogenesis of polycystic ovary syndrome: Lessons from ovarian stimulation studies, J. Endocrinol. Investig., 21, 567, 10.1007/BF03350782 · DOI
- Barbieri, 1986, Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism, J. Clin. Endocrinol. Metab., 62, 904, 10.1210/jcem-62-5-904 · DOI · Paper page
- Nestler, 1997, Insulin regulation of human ovarian androgens, Hum. Reprod., 12, 53, 10.1093/humrep/12.suppl_1.53 · DOI · Paper page
- Nestler, 1997, Role of Hyperinsulinemia in the Pathogenesis of the Polycystic Ovary Syndrome, and Its Clinical Implications, Semin. Reprod. Med., 15, 111, 10.1055/s-2007-1016294 · DOI · Paper page
- Dunaif, 1992, Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome, Diabetes, 41, 1257, 10.2337/diab.41.10.1257 · DOI · Paper page
- Corbould, 2006, Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome, Diabetes, 55, 751, 10.2337/diabetes.55.03.06.db05-0453 · DOI · Paper page
- Book, 1999, Selective insulin resistance in the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 84, 3110
- Kouli, 1999, A survey of the polycystic ovary syndrome in the Greek island of Lesbos: Hormonal and metabolic profile, J. Clin. Endocrinol. Metab., 84, 4006, 10.1210/jcem.84.11.6148 · DOI · Paper page
- Grulet, 1993, Roles of LH and insulin resistance in lean and obese polycystic ovary syndrome, Clin. Endocrinol., 38, 621, 10.1111/j.1365-2265.1993.tb02144.x · DOI · Paper page
- Dunaif, 1997, Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis, Endocr. Rev., 18, 774
- Artini, 2010, Best methods for identification and treatment of PCOS, Minerva Ginecol., 62, 33
- Costello, 2012, Evidence-Based Lifestyle and Pharmacological Management of Infertility in Women with Polycystic Ovary Syndrome, Womens Health, 8, 277
- Bates, 2012, Longterm management of Polycystic Ovarian Syndrome (PCOS), Mol. Cell. Endocrinol., 373, 91, 10.1016/j.mce.2012.10.029 · DOI · Paper page
- Carmina, 2012, Obesity, Adipokines and Metabolic Syndrome in Polycystic Ovary Syndrome, Front. Horm. Res., 40, 40, 10.1159/000341840 · DOI
- Mirza, 2014, Association between circulating adiponectin levels and polycystic ovarian syndrome, J. Ovarian Res., 7, 18, 10.1186/1757-2215-7-18 · DOI
- Sarray, 2015, Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome, Fertil. Steril., 104, 460, 10.1016/j.fertnstert.2015.05.007 · DOI
- Noroozzadeh, 2017, The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines, J. Endocrinol. Investig., 40, 859, 10.1007/s40618-017-0650-x · DOI
- Holte, 1994, The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women, Clin. Endocrinol., 41, 473, 10.1111/j.1365-2265.1994.tb02578.x · DOI · Paper page
- Marshall, 1999, NEUROENDOCRINE ASPECTS OF POLYCYSTIC OVARY SYNDROME, Endocrinol. Metab. Clin. N. Am., 28, 295, 10.1016/S0889-8529(05)70071-2 · DOI
- Li, 2020, Age-specific reference ranges of serum anti-müllerian hormone in healthy women and its application in diagnosis of polycystic ovary syndrome: A population study, BJOG Int. J. Obstet. Gynaecol., 127, 720, 10.1111/1471-0528.16147 · DOI
- Jacob, 2016, Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome, Clin. Endocrinol., 86, 395, 10.1111/cen.13269 · DOI
- Laven, 2017, Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: Redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis, Hum. Reprod., 32, 1723, 10.1093/humrep/dex226 · DOI
- Matsuzaki, 2017, Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome, Endocr. J., 64, 531, 10.1507/endocrj.EJ16-0501 · DOI
- Sathyapalan, 2018, Anti-Müllerian hormone measurement for the diagnosis of polycystic ovary syndrome, Clin. Endocrinol., 88, 258, 10.1111/cen.13517 · DOI
- Ahmed, N., Batarfi, A.A., Bajouh, O.S., and Bakhashab, S. (2019). Serum Anti-Müllerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms. Diagnostics, 9. · DOI
- Karkanaki, 2009, Adiponectin levels reflect the different phenotypes of polycystic ovary syndrome: Study in normal weight, normoinsulinemic patients, Fertil. Steril., 92, 2078, 10.1016/j.fertnstert.2009.06.034 · DOI
- Niafar, 2015, Adiponectin as serum biomarker of insulin resistance in patients with polycystic ovarian syndrome, Gynecol. Endocrinol., 31, 1, 10.3109/09513590.2015.1008445 · DOI
- Chan, 2007, Increased plasma visfatin concentrations in women with polycystic ovary syndrome, Fertil. Steril., 88, 401, 10.1016/j.fertnstert.2006.11.120 · DOI
- Kowalska, 2007, Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome, Hum. Reprod., 22, 1824, 10.1093/humrep/dem118 · DOI · Paper page
- Panidis, 2008, Plasma visfatin levels in normal weight women with polycystic ovary syndrome, Eur. J. Intern. Med., 19, 406, 10.1016/j.ejim.2007.05.014 · DOI
- Gen, 2009, Plasma visfatin level in lean women with PCOS: Relation to proinflammatory markers and insulin resistance, Gynecol. Endocrinol., 25, 241, 10.1080/09513590802585613 · DOI
- Tarkun, 2010, Plasma visfatin level in women with polycystic ovary syndrome, Gynecol. Endocrinol., 27, 475
- Farshchian, 2014, Visfatin and resistin serum levels in normal-weight and obese women with polycystic ovary syndrome, Int. J. Endocrinol. Metab., 12, 15503, 10.5812/ijem.15503 · DOI
- Lewandowski, 2005, Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: A significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices, Mol. Genet. Metab., 85, 61, 10.1016/j.ymgme.2004.12.014 · DOI
- Seow, 2004, Serum and adipocyte resistin in polycystic ovary syndrome with insulin resistance, Hum. Reprod., 19, 48, 10.1093/humrep/deh010 · DOI
- Munir, 2005, Resistin stimulation of 17alpha-hydroxylase activity in ovarian theca cells in vitro: Relevance to polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 90, 4852, 10.1210/jc.2004-2152 · DOI · Paper page
- Zheng, 2016, Leptin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and a Meta-Analysis, Reprod. Sci., 24, 656, 10.1177/1933719116670265 · DOI
- Mantzoros, 1997, Leptin concentrations in the polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 82, 1687
- Baldani, 2019, Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality, Gynecol. Endocrinol., 35, 401, 10.1080/09513590.2018.1534096 · DOI
- The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2012). Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Hum. Reprod., 27, 14–24. · DOI · Paper page
- Hoeger, 2008, Exercise Therapy in Polycystic Ovary Syndrome, Semin. Reprod. Med., 26, 93, 10.1055/s-2007-992929 · DOI
- Giallauria, 2008, Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS), Clin. Endocrinol., 69, 792, 10.1111/j.1365-2265.2008.03305.x · DOI
- Orio, 2008, Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women, Clin. Endocrinol., 68, 976, 10.1111/j.1365-2265.2007.03117.x · DOI
- Orio, 2016, Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: A randomized controlled trial, Clin. Endocrinol., 85, 764, 10.1111/cen.13112 · DOI · Paper page
- Lopes, 2018, Comparison of the Effect of Intermittent and Continuous Aerobic Physical Training on Sexual Function of Women With Polycystic Ovary Syndrome: Randomized Controlled Trial, J. Sex. Med., 15, 1609, 10.1016/j.jsxm.2018.09.002 · DOI · Paper page
- Ribeiro, V.B., Lopes, I.P., Dos Reis, R.M., Silva, R.C., Mendes, M.C., Melo, A.S., de Souza, H.C.D., Ferriani, R.A., Kogure, G.S., and Lara, L.A.D.S. (2019). Continuous versus intermittent aerobic exercise in the improvement of quality of life for women with polycystic ovary syndrome: A randomized controlled trial. J. Health Psychol. · DOI
- Ribeiro, V.B., Kogure, G.S., Lopes, I.P., Silva, R.C., Pedroso, D.C.C., de Melo, A.S., de Souza, H.C.D., Ferriani, R.A., Miranda Furtado, C.L., and Dos Reis, R.M. (2020). Effects of continuous and intermittent aerobic physical training on hormonal and metabolic profile, and body composition in women with polycystic ovary syndrome: A randomized controlled trial. Clin. Endocrinol. · DOI
- Brown, 2009, Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome, Med. Sci. Sports Exerc., 41, 497, 10.1249/MSS.0b013e31818c6c0c · DOI · Paper page
- Baghaei, 2012, Effects of acupuncture and exercise on insulin sensitivity, adipose tissue characteristics, and markers of coagulation and fibrinolysis in women with polycystic ovary syndrome: Secondary analyses of a randomized controlled trial, Fertil. Steril., 97, 501, 10.1016/j.fertnstert.2011.11.010 · DOI
- Leonhardt, 2015, Serum anti-Müllerian hormone and ovarian morphology assessed by magnetic resonance imaging in response to acupuncture and exercise in women with polycystic ovary syndrome: Secondary analyses of a randomized controlled trial, Acta Obstet. Gynecol. Scand., 94, 279, 10.1111/aogs.12571 · DOI
- Jedel, 2011, Impact of electro-acupuncture and physical exercise on hyperandrogenism and oligo/amenorrhea in women with polycystic ovary syndrome: A randomized controlled trial, Am. J. Physiol. Metab., 300, E37
- Moran, 2011, Exercise decreases anti-müllerian hormone in anovulatory overweight women with polycystic ovary syndrome: A pilot study, Horm. Metab. Res., 43, 977, 10.1055/s-0031-1291208 · DOI · Paper page
- Stepto, 2020, Exercise and insulin resistance in PCOS: Muscle insulin signalling and fibrosis, Endocr. Connect., 9, 346, 10.1530/EC-19-0551 · DOI
- Hutchison, 2012, Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome, Diabetologia, 55, 1424, 10.1007/s00125-011-2442-8 · DOI
- Scott, D., Teede, H.J., Rachoń, D., Harrison, C.L., Strauss, B.J., and Stepto, N.K. (2017). Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome. PLoS ONE, 12. · DOI
- Moro, 2009, Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 94, 2579, 10.1210/jc.2009-0051 · DOI · Paper page
- Redman, 2011, Aerobic exercise in women with polycystic ovary syndrome improves ovarian morphology independent of changes in body composition, Fertil. Steril., 95, 2696, 10.1016/j.fertnstert.2011.01.137 · DOI · Paper page
- Covington, 2014, Higher circulating leukocytes in women with PCOS is reversed by aerobic exercise, Biochimie, 124, 27, 10.1016/j.biochi.2014.10.028 · DOI
- Sprung, 2013, Exercise training in polycystic ovarian syndrome enhances flow-mediated dilation in the absence of changes in fatness, Med. Sci. Sports Exerc., 45, 2234, 10.1249/MSS.0b013e31829ba9a1 · DOI
- Sprung, 2013, Nitric oxide-mediated cutaneous microvascular function is impaired in polycystic ovary sydrome but can be improved by exercise training, J. Physiol., 591, 1475, 10.1113/jphysiol.2012.246918 · DOI
- Aye, 2018, Dynamic Change in Insulin Resistance Induced by Free Fatty Acids Is Unchanged Though Insulin Sensitivity Improves Following Endurance Exercise in PCOS, Front. Endocrinol., 9, 592, 10.3389/fendo.2018.00592 · DOI
- Halama, 2019, Metabolomics of Dynamic Changes in Insulin Resistance Before and After Exercise in PCOS, Front. Endocrinol., 10, 116, 10.3389/fendo.2019.00116 · DOI · Paper page
- Randeva, 2002, Exercise decreases plasma total homocysteine in overweight young women with polycystic ovary syndrome, J. Clin. Endocrinol. Metab., 87, 4496, 10.1210/jc.2001-012056 · DOI · Paper page
- Joham, 2012, Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: Impact of exercise training, Obesity, 20, 2390, 10.1038/oby.2012.135 · DOI
- Aktaş, H., Uzun, Y.E., Kutlu, O., Pençe, H.H., Özçelik, F., Çil, E., Irak, L., Altun, Ö., Özcan, M., and Özsoy, N. (2019). The effects of high intensity-interval training on vaspin, adiponectin and leptin levels in women with polycystic ovary syndrome. Arch. Physiol. Biochem., 1–6. · DOI
- Nybacka, 2013, Serum antimüllerian hormone in response to dietary management and/or physical exercise in overweight/obese women with polycystic ovary syndrome: Secondary analysis of a randomized controlled trial, Fertil. Steril., 100, 1096, 10.1016/j.fertnstert.2013.06.030 · DOI
- Legro, 2012, Obesity and PCOS: Implications for diagnosis and treatment, Semin. Reprod. Med., 30, 496, 10.1055/s-0032-1328878 · DOI · Paper page
- Ramos, 2015, A Nonrandomized Trial of Progressive Resistance Training Intervention in Women With Polycystic Ovary Syndrome and Its Implications in Telomere Content, Reprod. Sci., 23, 644
- Kogure, 2018, Hyperandrogenism Enhances Muscle Strength After Progressive Resistance Training, Independent of Body Composition, in Women With Polycystic Ovary Syndrome, J. Strength Cond. Res., 32, 2642, 10.1519/JSC.0000000000002714 · DOI
- Kogure, 2019, Effects of Progressive Resistance Training on Obesity Indices in Polycystic Ovary Syndrome and the Relationship With Telomere Length, J. Phys. Act. Health, 16, 601, 10.1123/jpah.2018-0256 · DOI
- Ramos, 2016, Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise Training, Rev. Bras. Ginecol. Obstet., 38, 340, 10.1055/s-0036-1585457 · DOI
- Nidhi, 2012, Effect of a yoga program on glucose metabolism and blood lipid levels in adolescent girls with polycystic ovary syndrome, Int. J. Gynaecol. Obstet., 118, 37, 10.1016/j.ijgo.2012.01.027 · DOI
- Patel, 2020, Regular Mindful Yoga Practice as a Method to Improve Androgen Levels in Women With Polycystic Ovary Syndrome: A Randomized, Controlled Trial, J. Am. Osteopath. Assoc., 120, 323
- Dantas, 2015, GLUT4 translocation is not impaired after acute exercise in skeletal muscle of women with obesity and polycystic ovary syndrome, Obesity, 23, 2207, 10.1002/oby.21217 · DOI
- Giallauria, 2008, Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome, Clin. Endocrinol., 68, 88, 10.1111/j.1365-2265.2007.03004.x · DOI · Paper page
- Rizk, 2007, Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome, Reprod. Biomed. Online, 15, 495, 10.1016/S1472-6483(10)60379-3 · DOI
- 2011, Diet composition and physical activity in overweight and obese premenopausal women with or without polycystic ovary syndrome, Gynecol. Endocrinol., 27, 978, 10.3109/09513590.2011.579658 · DOI
- Moran, 2017, Weight management practices associated with PCOS and their relationships with diet and physical activity, Hum. Reprod., 32, 669
- Greenwood, 2016, Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure, Fertil. Steril., 105, 486, 10.1016/j.fertnstert.2015.10.020 · DOI
- Eleftheriadou, 2012, Exercise and sedentary habits among adolescents with PCOS, J. Pediatr. Adolesc. Gynecol., 25, 172, 10.1016/j.jpag.2011.11.009 · DOI
- Barr, 2011, Habitual dietary intake, eating pattern and physical activity of women with polycystic ovary syndrome, Eur. J. Clin. Nutr., 65, 1126, 10.1038/ejcn.2011.81 · DOI
- Cramer, 2016, A Systematic Review and Meta-Analysis Estimating the Expected Dropout Rates in Randomized Controlled Trials on Yoga Interventions, Evid. Based Complement. Altern. Med., 2016, 5859729, 10.1155/2016/5859729 · DOI · Paper page
Cited by
Calcaterra, V., Verduci, E., Cena, H., Magenes, V. C., Todisco, C. F., Tenuta, E., Gregorio, C., De Giuseppe, R., Bosetti, A., Di Profio, E., et al. (2021) · Nutrients · doi:10.3390/nu13061848 · Cited by 183
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome
Bril, F., Ezeh, U., Amiri, M., Hatoum, S., Pace, L., Chen, Y.-H., Bertrand, F., Gower, B., & Azziz, R. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad356 · Cited by 123
The Role of Lifestyle Interventions in PCOS Management: A Systematic Review
Gautam, R., Maan, P., Jyoti, A., Kumar, A., Malhotra, N., & Arora, T. (2025) · Nutrients · doi:10.3390/nu17020310 · Cited by 115
“It may regulate menstrual periods by lowering insulin levels and enhancing ovarian function [144,145].”
Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome
Wang, D., & He, B. (2022) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s362424 · Cited by 28
Muhammed Saeed, A. A., Noreen, S., Awlqadr, F. H., Farooq, M. I., Qadeer, M., Rai, N., Farag, H. A., & Saeed, M. N. (2025) · Journal of Health, Population and Nutrition · doi:10.1186/s41043-025-00899-y · Cited by 29
“Conversely, minute amounts of essential minerals such as zinc, selenium, or copper are recommended to make life prosper [132].”
Metadata
- Authors
- Shele, G., Genkil, J., & Speelman, D.
- Venue
- Journal of Functional Morphology and Kinesiology
- Publisher
- MDPI AG
- Published
- 2020-05-31
- Volume
- 5
- Issue
- 2
- Pages
- 35
- ISSN
- 2411-5142 (ISSN-L)
- OpenAlex
- W3029051490
- Cited by
- 115
- References
- 41
- FWCI
- 3.13
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- American Osteopathic Association (181627705)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.